Caprelsa 300 mg, comprimés pelliculés

7680623410023 CH-62341 Tabletten
Caprelsa 300 mg, comprimés pelliculés
Caprelsa 300 mg, comprimés pelliculés
Caprelsa 300 mg, comprimés pelliculés
1 / 3
google

Article details

Package size
30
Selling units
30
Measure
Tablette(n)
Galenic form
Tabletten
Galenic group
Tabletten

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
19/06/2025
Patient information leaflet
Français
19/06/2025
Patient information leaflet
Italien
19/06/2025
Summary of Product Characteristics
Allemand
19/06/2025
Summary of Product Characteristics
Français
19/06/2025
Summary of Product Characteristics
Italien
19/06/2025

Detailed composition

Substance Quantity Type Category
(N/A)
300.0 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance Hilfsstoff ohne Deklarationspflicht (Excipient sans obligation de déclaration)
(N/A)
- Substance FNIDK

Reimbursement information

Public price
CHF 4907.65
Specialties list
Yes
Generic
No

Reimbursement limitation

SL addition date: 01/12/2012

Authorization holder

Sanofi-Aventis (Suisse) SA

1214 Vernier

Authorization information

Swissmedic authorization number
62341
Drug name
Caprelsa, comprimés pelliculés
Galenic form
TAB
ATC Code
L01EX04
Authorization status
Z
Dispensing category
A
First authorization
01/05/2012
Authorization expiration date
31/12/9999
IT Number
07.16.1.
Domain
Human medicine
Field of application
Medulläres Schilddrüsenkarzinom

Package details

Description (FR)
CAPRELSA cpr pell 300 mg 30 pce
Description (DE)
CAPRELSA Filmtabl 300 mg 30 Stk
Market launch
01/05/2012
Narcotic (BTM)
No

Other package sizes (1)

CAPRELSA cpr pell 100 mg 30 pce
30 TABL
GTIN: 7680623410016
View